Delivery Order SPE2DX15D9901-SPE2DX21FPUNN
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,434.00 and has a firm fixed price pricing type. The contract is for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at up to...
- This is a Delivery Order (DO) contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is valued at $1,434.00 and has a period of performance through September 3, 2021. The contract provides for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. This DO is part of a larger Indefinite Delivery Contract (IDC) with DMS...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, with a ceiling value of $74,921.76 and a completion date of July 11, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a wide range of medical supplies...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Naloxone Hydrochloride, a medication used to treat opioid overdoses, with a ceiling value of $3,188.40 and a completion date of June 9, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. DMS Pharmaceutical Group holds a...
- The U.S. government has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $1,594.20 and has a completion date of June 9, 2025. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose, to the Defense Logistics Agency (DLA), which is the primary logistics and supply support agency for the U.S. Department of Defense. DMS...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,746.50 contract is for the delivery of 10 units of 1mg/mL Naloxone, a medication used to reverse opioid overdose. The award has a completion date of June 16, 2025 and is not set aside for any specific business category. DMS Pharmaceutical Group holds a significant $499,999,999...
- This federal contract award from the Defense Logistics Agency (DLA) was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,512.54 firm fixed-price delivery order covers the supply of 8510882567 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
- This federal contract award, valued at $11,025.08, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Naloxone Hydrochloride, a medication used to reverse opioid overdose. The contract is not associated with a set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA,...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $11,099.52 firm fixed-price contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdoses. The contract has an ultimate completion date of July 28, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of 4562900589 - NALOXONE 2 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $1,529.30 and a period of performance through November 28, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical...
- SPE2DX15D9901Indefinite Delivery Contract
- SPE2DX15D9901-SPE2DX21FPUNNDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), under the Medical Supply Chain program, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,434.00, is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This single-award IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/2/21 |